For the financial year ended 31 December 2015
83
ANNUAL REPORT 2015
13. INVESTMENT IN ASSOCIATED COMPANIES
(CONTINUED)
(b) Information on material associated company as at and for the year ended 31 December 2014
Set out below is the information on HHHI, which was a material associate to the Group as at 31 December 2014.
HHHI’s share capital consists solely of ordinary shares.
Name of company
Country of
incorporation
Principal activities
% of ownership
interest at 31
December 2014
Hua Han Health Industry
Holdings Limited (“HHHI”)
Cayman Islands
Manufacturing and sale of
pharmaceutical products
14.4
HHHI, which is listed on the Hong Kong Stock Exchange, is an investment holding company with subsidiaries
which operate mainly in the People’s Republic of China and its principal activity is that of manufacturing and
sale of pharmaceutical products, trading of pharmaceutical products and the research and development of
pharmaceutical products.
At 31 December 2014, the Group’s investment in HHHI had a carrying amount denominated in Hong Kong dollar
with a Singapore dollar equivalent of $134,208,000. The fair value of the investment based on quoted bid price
was $229,893,000.
There are no contingent liabilities relating to the Group’s interest in the associated company.
Set out below is the summarised prior year financial information for HHHI.
Summarised statement of financial position
2014
$’000
Current assets
566,068
Includes:
- Cash and cash equivalents
342,941
Current liabilities
(78,481)
Includes:
- Financial liabilities (excluding trade and other payables)
(39,781)
Non-current assets
490,377
NOT E S TO T H E F I NAN C I A L S TAT EME N T S
(CONTINUED)
